About N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide
N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide (PubChem CID 121112734) has the molecular formula C15H15N7O2
and a molecular weight of 325.33 g/mol. Its IUPAC name is N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide.
Analyze N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide?
The IUPAC name of N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide (CID 121112734) is N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide.
What is the SMILES notation for N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide?
The canonical SMILES for N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide is Cc1ncn(-c2ncc(NC(=O)COc3ncccn3)cn2)c1C.
What is the InChIKey of N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide?
The InChIKey is SDZQRFQNMNGABP-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H15N7O2/c1-10-11(2)22(9-20-10)14-18-6-12(7-19-14)21-13(23)8-24-15-16-4-3-5-17-15/h3-7,9H,8H2,1-2H3,(H,21,23).
What are the key properties of N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide?
N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide has a molecular weight of 325.33 g/mol, XLogP of 1.09, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4,5-dimethylimidazol-1-yl)pyrimidin-5-yl]-2-pyrimidin-2-yloxyacetamide is sourced from PubChem (CID 121112734), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).